Table 2. Calculated figures for cumulative uptake of predictive testing based on alternative parameter estimates.
| UK prevalence of HD (per 100 000 adult population) | Ratio of symptomatic individuals to individuals at 50% risk of developing HD | Calculated cumulative uptake (95% CI) (%) |
|---|---|---|
| 8 | 1:4.2 | 26.8 (25.9–27.6) |
| 8 | 1:5 | 22.3 (21.6–23.0) |
| 10 | 1:4.2 | 21.4 (20.7–22.1) |
| 10 | 1:5 | 17.8 (17.3–18.4) |
| 12 | 1:4.2 | 17.8 (17.3–18.4) |
| 12 | 1:5 | 14.9 (14.4–15.3) |
| 12.3 | 1:4.2 | 17.4 (16.9–18.0) |
| 12.3 | 1:5 | 14.5 (14.0–15.0) |
| 13 | 1:4.2 | 16.5 (16.0–17.0) |
| 13 | 1:5 | 13.7 (13.3–14.2) |